Press Releases
Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement wi...
Press Releases
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Product...
Press Releases
Genezen Secures $18.5 Million in Growth Equity to Expand Viral Vector Development and Manu...
Press Releases
Genezen Announces the Appointment of Steven J. Favaloro as Chief Executive Officer to Sup...
Press Releases
Genezen Delivers Next Phase of cGMP Lentiviral and Retroviral Vector Production Facility E...
Press Releases
Genezen, Monon Bioventures, and Purdue University Partnership to Develop Glioblastoma Ther...
Press Releases
Genezen Completes cGMP-Lentiviral and Retroviral Vector Clinical Production Facility Build...
Press Releases
Treadwell Therapeutics Engages Genezen to Advance its TCR Cell Therapy Pipeline
